Press Releases

  • Providence, RI--(BUSINESS WIRE)--Beech Tree Labs, Inc., announced today that the FDA has approved its IND for a 180 patient Phase 1/2a clinical evaluation of BTL-TML001, a novel therapeutic agent for treating acute influenza virus infections. In the United States it is estimated that outbreaks of...
Copyright Beech Tree Labs, Inc.